Arbi Khemichian, MD
NPI 1003056516 · Ophthalmology Physician · Torrance, CA
Enrolled with Medicare as Practitioner - Ophthalmology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1003056516
- Entity type
- Individual
- Primary specialty
- Ophthalmology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- Yes
- License
- N5775 (TX)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
17 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
2,302 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Complete Exam of Visual System92014 | 811 | $140 |
| Established Patient Problem Focused Exam of Visual System92012 | 336 | $98 |
| Measurement of Corneal Curvature and Depth of Eye92136 | 306 | $36 |
| Photography of the Retina92250 | 230 | $41 |
| New Patient Complete Exam of Visual System92004 | 160 | $164 |
| Removal of Cataract With Insertion of Prosthetic Lens66984 | 122 | $583 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 27 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ofloxacin | 174 | 118 |
| Latanoprost | 170 | 50 |
| Prednisolone Acetate | 162 | 102 |
| Cyclosporinebrand: Restasis | 123 | 32 |
| Tobramycin/Dexamethasonebrand: Tobramycin-Dexamethasone | 111 | 88 |
| Timolol Maleate | 103 | 31 |
| Bimatoprostbrand: Lumigan | 94 | 19 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$766 across 36 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2009-02-23
- Last updated
- 2017-02-22
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.